Johnson & Johnson halts COVID-19 vaccine trial after participant falls sick
In a significant development, Johnson & Johnson on Monday (October 12) announced that it had temporarily halted the trial of its coronavirus COVID-19 vaccine after one of its participants fell ill.
0 Comments